Skip to main content
G logo

G · Genpact LTD

Track G — free
$41.50 +0.66 (+1.62%) At close · Nov 20
Market Cap
$6.94B
Shares
167.23M
Volume · Nov 20 1.77M Avg daily vol (3M) 2.05M

Price & Indicators

 

Key stats

Close
$41.50
Fri 20 Nov
Open
$41.34
Fri 20 Nov
Average volume, 30 days
2.1M
shares a session
Short interest
10.7M
6.4% of shares · 6.0 days to cover
Day range
$41.25$42.34
Open $41.34 Close $41.50
52-week closing range
$27.50$48.50
Close $41.50 14.4% under the high
Short volume, last session
78%
Last earnings
Nov 5, 2026
Latest filing
10-Q · Nov 6
Price history
Jan 2020 to Nov 2026

Up next

Feb 4, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 12
Current report 8-K Events of Nov 10
Shareholders approve move to Delaware

Genpact Limited shareholders approved changing its jurisdiction of incorporation from Bermuda to Delaware, discontinuing as an exempted company limited by shares and continuing as a Delaware corporation.

Shareholder vote results
Source passage
Company shareholders approved the change of the Company’s jurisdiction of incorporation from Bermuda to the State of Delaware by discontinuing as an exempted company limited by shares in Bermuda and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware. Open the document at this passage
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 7.3% as Advanced Technology Solutions expands 30.3%

Genpact Limited reported third-quarter net revenues of $1,385.4 million, up 7.3%, as Advanced Technology Solutions revenue grew 30.3% to $405.1 million. Income from operations rose to $211.0 million and adjusted income from operations to $246.5 million.

Revenue $1.39B ▲ 7.3% Net income $151.66M ▲ 4.0% Diluted EPS $0.89 ▲ 7.2%
Read from the MD&A section
5 source passages
Our name after the Domestication will remain “Genpact Limited.” Our net revenues were $1,385.4 million in the third quarter of 2026, up $94.1 million, or 7.3%, from $1,291.3 million in the third quarter of 2025. Net revenues from Advanced Technology Solutions in the third quarter of 2026 were $405.1 million, up $94.1 million, or 30.3%, from $311.0 million in the third quarter of 2025. Income from operations was $211.0 million in the third quarter of 2026, up $19.3 million from $191.6 million in the third quarter of 2025. adjusted income from operations (“AOI”) increased by $17.6 million to $246.5 million in the third quarter of 2026 from $228.9 million in the third quarter of 2025. Open the document at this passage
Nov 5
Earnings call
Revenue rises 7.3%; agentic bookings expected above $1 billion

Genpact reported Q3 revenue growth of 7.3% year-over-year and expects agentic bookings to exceed $1 billion by year-end 2026. Advanced technology solutions revenue grew 30.3%, and full-year revenue growth is expected to be at least 7%.

4 source passages
We delivered $1.385 billion in total revenue for the third quarter. This 7.3% year-over-year total revenue growth was delivered despite roughly two points of impact from our transition away from work not aligned with our agentic operation strategy. At the same time, advanced technology solutions revenue, which includes data and AI, digital technologies, advisory, and agent tech, reached $405 million this quarter, growing 30.3% year over year. Last quarter, I said we are on track to exceed $1 billion. In agentic solutions booking for 2026, our momentum has only strengthened. Now, I am pleased to report that we will exceed that number by a margin. For the full year 2026, we expect at least 7% revenue growth on an as-reported basis, given our strong backlog, pipeline, and ability to execute. Open the document at this passage
Nov 5
Current report 8-K
Revenue growth drives higher full-year margin and EPS guidance

Genpact reported third-quarter net revenues of $1.385 billion, up 7.3% year-over-year, and raised 2026 gross-margin guidance to approximately 36.9% and adjusted diluted EPS growth guidance to at least 13%.

Financial results
4 source passages
Net revenues were $1.385 billion, up 7.3% year-over-year, and 7.5% on a constant currency basis.2 Genpact's updated outlook for the full year 2026 is as follows: Gross margin outlook increased to approximately 36.9%, up approximately 90 basis points year-over-year. Adjusted diluted earnings per share5 growth increased to at least 13% year-over-year. Open the document at this passage
Oct 5
Registration statement S-4/A
Registration statement

Genpact Limited will seek shareholder approval on November 10, 2026 to move incorporation from Bermuda to Delaware, expected on or around March 1, 2027; common shares will convert into an equivalent number of Delaware common stock.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.34B
Trailing 12 months
Net income (TTM)
$588.48M
Trailing 12 months
Revenue growth YoY
+7.3%
Year over year
Operating margin
14.9%
Trailing 12 months
P / E (TTM)
12.1
Trailing earnings · reciprocal yield 8.3%
FCF yield
5.1%
TTM · current market cap
Return on invested capital
18.0%
Trailing 12 months
Net cash
−$675.11M
Latest balance sheet
Dividend yield
1.8%
Trailing 12 months
Shares change YoY
-3.7%
Year over year · fewer shares
Price change (1Y)
-5.1%
Trailing year
Short interest
6.4%
Latest settlement · 6.0 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. Genpact reported 7.3% total revenue growth, including 30.3% Advanced Technology Solutions growth, expanded gross margin, and raised full-year gross-margin and adjusted diluted EPS guidance; 2026 agentic bookings are expected to exceed $1 billion. Risks include flat Core Business Services revenue, transition-related revenue pressure that grows in 2027, slight Q4 Core Business Services weakness, higher SG&A expense, and ERP-related disruption of invoicing and collections.

Bullish
  • + Advanced Technology Solutions revenue grew 30.3% year-over-year to $405 million. new
  • + Gross profit grew 12.1% year-over-year as gross margin reached 38.0%. new
  • + Full-year 2026 gross-margin guidance increased to approximately 36.9%, up approximately 90 basis points year-over-year. new
  • + Management expects 2026 agentic bookings to exceed $1 billion, more than five times 2025 bookings. new
  • + Total revenue grew 7.3% year-over-year to $1.385 billion. new
Bearish
  • − Core Business Services revenue was flat year-over-year at $980 million. new
  • − The transition away from work not aligned with the Agentic Operations strategy reduced Q3 revenue growth by roughly two points. new
  • − The dollar impact from transitioned work is expected to be modestly larger in 2027 than in 2026. new
  • − Q4 Core Business Services revenue is expected to decline slightly. new
  • − SG&A expense increased to 22.6% of revenue, up roughly two points year-over-year. new
  • − The recent ERP implementation delayed invoicing and collections, affecting Q3 operating cash flow. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +17%
above
Price vs 50-day avg +10%
above
RSI (14) 55
neutral
MACD trend Negative
52-week position 67%
mid-range
Momentum
relative strength
Strong
1-month return +2%
trailing
6-month return +26%
trailing
YTD return −11%
this year
Relative strength +35%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $38 › 200d $35 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +73 funds added
Insider flow Distributing
Net -$9.1M over 90 days · 100% sells
Short interest Falling
6.39% of shares out · ▼ -3.6% MoM · 6.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
492 holders — mid 3-yr range
Squeeze score 73
high risk · 0–100
Fundamentals
Excellent
Revenue growth +7%
Y/Y
Gross margin 80%
expanding
EPS growth +10%
Y/Y
Free cash flow $734.7M
Valuation P/E 12.1
below peers
Buyback $213.2M
remaining
Balance sheet $688.5M
net debt
Quant / Vol
risk profile
High
Volatility 38%
annualized · 1-yr
Max drawdown −43%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 7 of last 8
Latest guidance · from the 8-K filed Nov 5, 2026
Net revenue growth · full year 2026 at least 7%
Net revenue growth on a constant currency basis · full year 2026 Non-GAAP Initiated 6.8%
In Advanced Technology Solutions, revenue growth · full year 2026 Initiated at least 25%
Gross margin outlook · full year 2026 Raised 36.9%
May 7, 2026 36.5% changed to Nov 5, 2026 36.9%
Adjusted income from operations margin · full year 2026 Non-GAAP Maintained 17.7%
Aug 6, 2026 17.7% changed to Nov 5, 2026 17.7%
Adjusted diluted earnings per share growth · full year 2026 Non-GAAP at least 13%
Previous outlook earlier release · from the Earnings Call filed Aug 6, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted operating income margin · 2026 17.7%
Adjusted diluted EPS · 2026 at least 12%
ATS growth · this year 25%
Prior guidance period ended · from the Earnings Call filed Aug 6, 2026
Total revenue · the third quarter $1.37B – $1.38B
Gross margin · the third quarter 36.6%
Adjusted operating income margin · the third quarter 17.8%
Adjusted diluted EPS · the third quarter $1.04 – $1.05
Guided vs delivered · last 8 settled
Total revenue the third quarter
guided $1.37B – $1.38B
$1.39B Beat +0.7%
Net revenues second quarter of 2026
guided $1.32B – $1.34B
$1.34B Beat +1.0%
Total revenue first quarter 2026
guided $1.28B – $1.29B
$1.3B Beat +0.6%
Net revenue fourth quarter
guided $1.3B – $1.31B
$1.32B Beat +1.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+17% Bullish
Price vs 50-day avg
+10% Bullish
RSI (14)
55 Neutral
MACD trend
Negative Bearish
52-week position
67% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $38 › 200d $35 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +73 funds added
Insider flow Distributing
Net -$9.1M over 90 days · 100% sells
Short interest Falling
6.39% of shares out · ▼ -3.6% MoM · 6.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
492 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $28 Now $42 · 67% Range high $49
vs 200-day avg +17% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
AOI margin non-GAAP 17.8% the third quarter of 2026 filing —
constant currency basis non-GAAP 7.5% the third quarter of 2026 compared to the third quarter of 2025 filing —
Total Number of Shares Purchased 871,787 the three months ended September 30, 2026 filing —
Total reportable segment AOI non-GAAP $277.4M the three months ended September 30, 2026 filing —
Unallocated corporate expenses non-GAAP -$30.8M the three months ended September 30, 2026 filing —
Average price per share repurchased $35.49 Q3 2026 —
Capital returned to shareholders through share repurchases and dividends $246M Year-to-date 2026 —
Cash generated from operations $93M Q3 2026 —
Shares repurchased 870,000 Q3 2026 —
gross margin 36.5% the second quarter of 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Information Technology Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
G
Genpact LTD
this stock
$6.94B -11.3% +6.9% 12.1 6.4%
IBM
International Business Machines Corp
$212.12B -24.2% +7.6% 19.1 1.9%
ACN
Accenture plc
$147.97B -17.6% +6.5% 16.3 3.2%
INFY
Infosys Ltd
$48.73B -32.5% — — 2.1%
CTSH
Cognizant Technology Solutions Corp
$25.95B -30.0% +7.0% 10.6 5.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
492
% held
103.8%
Net QoQ
-6.3M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
185
View
Short & Settlement
Short Interest Falling
Shares short
10.7M
Days to cover
6.0d
Change
-401.6K sh
View
Short Volume
Short vol %
78%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
463
Value
$18.1K
As of
Oct 28, 2026
View
Off-Exchange
Off-exchange %
39.9%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$9.1M
Buyers / Sellers
0 / 3
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$5.1B
Net income (FY)
$552.5M
EPS diluted
$3.13
View
Buybacks
Authorized
$2.8B
Remaining
$213.2M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 12, 2026
This year
18

Genpact Limited shareholders approved changing its jurisdiction of incorporation from Bermuda to Delaware, discontinuing as an exempted company limited by shares and continuing as a Delaware corporation.

View
Proposed Sales
Value
$8.6M
Shares
200.0K
Filed
Nov 10, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Genpact Launches Genpact Onyx, th…
Published
Nov 16, 2026
View

Performance

5D 20D 120D MTD YTD
G -4.8% +1.6% +25.6% +4.8% -11.3%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY +3.7% +10.9% +34.8% +13.5% -12.5%

Capital returns

Latest dividend
$0.188 / share · ex Sep 10, 2026
Declared · upcoming
$0.1875 / share · ex Dec 10, 2026
Raised 10.6%
Paid (TTM)
$0.734 / share · 4 payouts
Dividend yield (TTM, derived)
1.77%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$2.75B
Spent (derived)
$2.54B
Remaining
$213.19M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1398659 CUSIP G3922B107 13F (30d) 458 filings 416 filers Visit website Investor relations